{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:46:20Z","timestamp":1790664380305,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T00:00:00Z","timestamp":1683763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft, Germany","award":["Project-ID 431984000\u2014CRC 1453 Nephrogenetics"],"award-info":[{"award-number":["Project-ID 431984000\u2014CRC 1453 Nephrogenetics"]}]},{"name":"Nutricia Metabolics Research Fund","award":["ZVK2019012903"],"award-info":[{"award-number":["ZVK2019012903"]}]},{"name":"Freiburg Center for Rare Diseases"},{"name":"Division of Inborn Errors of Metabolism at the Department of Pediatrics"},{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Methylmalonic aciduria (MMA-uria) is caused by deficiency of the mitochondrial enzyme methylmalonyl-CoA mutase (MUT). MUT deficiency hampers energy generation from specific amino acids, odd-chain fatty acids and cholesterol. Chronic kidney disease (CKD) is a well-known long-term complication. We exposed human renal epithelial cells from healthy controls and MMA-uria patients to different culture conditions (normal treatment (NT), high protein (HP) and isoleucine\/valine (I\/V)) to test the effect of metabolic stressors on renal mitochondrial energy metabolism. Creatinine levels were increased and antioxidant stress defense was severely comprised in MMA-uria cells. Alterations in mitochondrial homeostasis were observed. Changes in tricarboxylic acid cycle metabolites and impaired energy generation from fatty acid oxidation were detected. Methylcitrate as potentially toxic, disease-specific metabolite was increased by HP and I\/V load. Mitophagy was disabled in MMA-uria cells, while autophagy was highly active particularly under HP and I\/V conditions. Mitochondrial dynamics were shifted towards fission. Sirtuin1, a stress-resistance protein, was down-regulated by HP and I\/V exposure in MMA-uria cells. Taken together, both interventions aggravated metabolic fingerprints observed in MMA-uria cells at baseline. The results point to protein toxicity in MMA-uria and lead to a better understanding, how the accumulating, potentially toxic organic acids might trigger CKD.<\/jats:p>","DOI":"10.1038\/s41598-023-34373-8","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T13:02:05Z","timestamp":1683810125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The impact of metabolic stressors on mitochondrial homeostasis in a renal epithelial cell model of methylmalonic aciduria"],"prefix":"10.1038","volume":"13","author":[{"given":"Anke","family":"Schumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Brutsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Havermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Gr\u00fcnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"K\u00f6lker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Gro\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Hannibal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Spiekerkoetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,11]]},"reference":[{"issue":"3","key":"34373_CR1","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/jimd.12370","volume":"44","author":"P Forny","year":"2021","unstructured":"Forny, P. et al. Guidelines for the diagnosis and management of methylmalonic acidaemia ***and propionic acidaemia: First revision. J. Inherit. Metab. Dis. 44(3), 566\u2013592 (2021).","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"34373_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/jimd.12254","volume":"44","author":"B Dimitrov","year":"2021","unstructured":"Dimitrov, B. et al. Organic acidurias: Major gaps, new challenges, and a yet unfulfilled promise. J. Inherit. Metab. Dis. 44(1), 9\u201321 (2021).","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"34373_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/jimd.12297","volume":"44","author":"F H\u00f6rster","year":"2021","unstructured":"H\u00f6rster, F. et al. Delineating the clinical spectrum of isolated methylmalonic acidurias: cblA and mut. J. Inherit. Metab. Dis. 44(1), 193\u2013214 (2021).","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"34373_CR4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1203\/PDR.0b013e3180a0325f","volume":"62","author":"F H\u00f6rster","year":"2007","unstructured":"H\u00f6rster, F. et al. Long-term outcome in methylmalonic acidurias is influenced by the underlying defect (mut0, mut-, cblA, cblB). Pediatr. Res. 62(2), 225\u2013230 (2007).","journal-title":"Pediatr. Res."},{"key":"34373_CR5","doi-asserted-by":"crossref","first-page":"1246069","DOI":"10.1155\/2018\/1246069","volume":"20","author":"E Richard","year":"2018","unstructured":"Richard, E. et al. Altered redox homeostasis in branched-chain amino acid disorders, organic acidurias, and homocystinuria. Oxid. Med. Cell. Longev. 20, 1246069 (2018).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"34373_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ymgme.2018.01.009","volume":"123","author":"A Imbard","year":"2018","unstructured":"Imbard, A. et al. Long-term liver disease in methylmalonic and propionic acidemias. Mol. Genet. Metab. 123, 433\u2013440 (2018).","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"34373_CR7","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1096\/fj.08-121848","volume":"23","author":"RJ Chandler","year":"2009","unstructured":"Chandler, R. J. et al. Mitochondrial dysfunction in mut methylmalonic acidemia. FASEB J. 23(4), 1252\u20131261 (2009).","journal-title":"FASEB J."},{"issue":"1","key":"34373_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1203\/PDR.0b013e3181a7c270","volume":"66","author":"Y de Keyzer","year":"2009","unstructured":"de Keyzer, Y. et al. Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr. Res. 66(1), 91\u201395 (2009).","journal-title":"Pediatr. Res."},{"issue":"33","key":"34373_CR9","doi-asserted-by":"publisher","first-page":"13552","DOI":"10.1073\/pnas.1302764110","volume":"110","author":"I Manoli","year":"2013","unstructured":"Manoli, I. et al. Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia. Proc. Natl. Acad. Sci. U.S.A. 110(33), 13552\u201313557 (2013).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"34373_CR10","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41467-020-14729-8","volume":"11","author":"A Luciani","year":"2020","unstructured":"Luciani, A. et al. Impaired mitophagy links mitochondrial disease to epithelial stress in methylmalonyl-CoA mutase deficiency. Nat. Commun. 11, 970 (2020).","journal-title":"Nat. Commun."},{"issue":"5","key":"34373_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/jimd.12129","volume":"42","author":"HA Haijes","year":"2019","unstructured":"Haijes, H. A. et al. Pathophysiology of propionic and methylmalonic acidemias. Part 1: Complications. J. Inherit. Metab. Dis. 42(5), 730\u2013744 (2019).","journal-title":"J. Inherit. Metab. Dis."},{"issue":"6","key":"34373_CR12","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/jimd.12419","volume":"44","author":"A Schumann","year":"2021","unstructured":"Schumann, A. et al. Mitochondrial damage in renal epithelial cells is potentiated by protein exposure in propionic aciduria. J. Inherit. Metab. Dis. 44(6), 1330\u20131342 (2021).","journal-title":"J. Inherit. Metab. Dis."},{"issue":"7","key":"34373_CR13","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1681\/ASN.2017111218","volume":"29","author":"M Morigi","year":"2018","unstructured":"Morigi, M., Perico, L. & Benigni, A. Sirtuins in renal health and disease. J. Am. Soc. Nephrol. 29(7), 1799\u20131809 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"34373_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneph.2017.107","volume":"13","author":"P Bhargava","year":"2017","unstructured":"Bhargava, P. & Schnellmann, R. G. Mitochondrial energetics in the kidney. Nat. Rev. Nephrol. 13(10), 629\u2013646 (2017).","journal-title":"Nat. Rev. Nephrol."},{"issue":"12","key":"34373_CR15","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1038\/s41436-019-0593-z","volume":"21","author":"OA Shchelochkov","year":"2019","unstructured":"Shchelochkov, O. A. et al. Chronic kidney disease in propionic acidemia. Genet. Med. 21(12), 2830\u20132835 (2019).","journal-title":"Genet. Med."},{"issue":"6","key":"34373_CR16","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s10545-015-9840-x","volume":"38","author":"S K\u00f6lker","year":"2015","unstructured":"K\u00f6lker, S. et al. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: The evolving clinical phenotype. J. Inherit. Metab. Dis. 38(6), 1059\u20131074 (2015).","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"34373_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2019.165622","volume":"1866","author":"M Lucienne","year":"2020","unstructured":"Lucienne, M. et al. In-depth phenotyping reveals common and novel disease symptoms in a hemizygous knock-in mouse model (Mut-ko\/ki) of mut-type methylmalonic aciduria. Biochim. Biophys. Acta Mol. Basis Dis. 1866(3), 165622 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"34373_CR18","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1750-1172-8-4","volume":"8","author":"P Jafari","year":"2013","unstructured":"Jafari, P. et al. Brain damage in methylmalonic aciduria: 2-methylcitrate induces cerebral ammonium accumulation and apoptosis in 3D organotypic brain cell cultures. Orphanet J. Rare Dis. 8, 4 (2013).","journal-title":"Orphanet J. Rare Dis."},{"issue":"1\u20132","key":"34373_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ymgme.2016.07.013","volume":"119","author":"HP Cudr\u00e9-Cung","year":"2016","unstructured":"Cudr\u00e9-Cung, H. P. et al. Ammonium accumulation is a primary effect of 2-methylcitrate exposure in an in vitro model for brain damage in methylmalonic aciduria. Mol. Genet. Metab. 119(1\u20132), 57\u201367 (2016).","journal-title":"Mol. Genet. Metab."},{"issue":"10","key":"34373_CR20","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/s41556-020-00579-5","volume":"22","author":"C Xu","year":"2020","unstructured":"Xu, C. et al. SIRT1 is downregulated by autophagy in senescence and ageing. Nat. Cell Biol. 22(10), 1170\u20131179 (2020).","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"34373_CR21","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41418-019-0369-7","volume":"27","author":"W Zhang","year":"2020","unstructured":"Zhang, W. et al. SIRT1 modulates cell cycle progression by regulating CHK2 acetylation-phosphorylation. Cell Death Differ. 27(2), 482\u2013496 (2020).","journal-title":"Cell Death Differ."},{"key":"34373_CR22","doi-asserted-by":"publisher","first-page":"E34","DOI":"10.1038\/s41586-019-1296-y","volume":"570","author":"TB Fonseca","year":"2019","unstructured":"Fonseca, T. B. et al. Mitochondrial fission requires DRP1 but not dynamins. Nature 570, E34\u2013E42 (2019).","journal-title":"Nature"},{"issue":"1","key":"34373_CR23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41467-022-28247-2","volume":"13","author":"JH Hwang","year":"2022","unstructured":"Hwang, J. H. et al. TAZ links exercise to mitochondrial biogenesis via mitochondrial transcription factor A. Nat. Commun. 13(1), 653 (2022).","journal-title":"Nat. Commun."},{"issue":"3","key":"34373_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.kint.2020.10.013","volume":"99","author":"K Ishii","year":"2021","unstructured":"Ishii, K. et al. Kidney epithelial targeted mitochondrial transcription factor A deficiency results in progressive mitochondrial depletion associated with severe cystic disease. Kidney Int. 99(3), 657\u2013670 (2021).","journal-title":"Kidney Int."},{"issue":"5","key":"34373_CR25","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/biology10050349","volume":"10","author":"R Prieto-Carrasco","year":"2021","unstructured":"Prieto-Carrasco, R. et al. Progressive reduction in mitochondrial mass is triggered by alterations in mitochondrial biogenesis and dynamics in chronic kidney disease induced by 5\/6 nephrectomy. Biology 10(5), 349 (2021).","journal-title":"Biology"},{"issue":"3","key":"34373_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ymgme.2020.05.003","volume":"130","author":"MS Collado","year":"2020","unstructured":"Collado, M. S. Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes. Mol. Genet. Metab. 130(3), 183\u2013196 (2020).","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"34373_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10545-007-0571-5","volume":"31","author":"MA Morath","year":"2008","unstructured":"Morath, M. A. et al. Neurodegeneration and chronic renal failure in methylmalonic aciduria\u2014A pathophysiological approach. J. Inherit. Metab. Dis. 31(1), 35\u201343 (2008).","journal-title":"J. Inherit. Metab. Dis."},{"issue":"24","key":"34373_CR28","first-page":"7049","volume":"24","author":"T Ruppert","year":"2015","unstructured":"Ruppert, T. et al. Molecular and biochemical alterations in tubular epithelial cells of patients with isolated methylmalonic aciduria. Hum. Mol. Genet. 24(24), 7049\u20137059 (2015).","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"34373_CR29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF00861581","volume":"7","author":"SL Rutledge","year":"1993","unstructured":"Rutledge, S. L. et al. Tubulointerstitial nephritis in methylmalonic acidemia. Pediatr. Nephrol. 7(1), 81\u201382 (1993).","journal-title":"Pediatr. Nephrol."},{"issue":"1","key":"34373_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1681\/ASN.2017030350","volume":"29","author":"F Afshinnia","year":"2018","unstructured":"Afshinnia, F. et al. Impaired \u03b2-oxidation and altered complex lipid fatty acid partitioning with advancing CKD. J. Am. Soc. Nephrol. 29(1), 295\u2013306 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"39","key":"34373_CR31","doi-asserted-by":"publisher","first-page":"20563","DOI":"10.1074\/jbc.M116.747717","volume":"291","author":"P Forny","year":"2016","unstructured":"Forny, P. et al. Novel mouse models of methylmalonic aciduria recapitulate phenotypic traits with a genetic dosage effect. J. Biol. Chem. 291(39), 20563\u201320573 (2016).","journal-title":"J. Biol. Chem."},{"issue":"2","key":"34373_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nrm.2017.129","volume":"19","author":"JW Harper","year":"2018","unstructured":"Harper, J. W., Ordureau, A. & Heo, J. M. Building and decoding ubiquitin chains for mitophagy. Nat. Rev. Mol. Cell. Biol. 19(2), 93\u2013108 (2018).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"6","key":"34373_CR33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","volume":"19","author":"I Dikic","year":"2018","unstructured":"Dikic, I. & Elazar, Z. Mechanism and medical implications of mammalian autophagy. Nat. Rev. Mol. Cell. Biol. 19(6), 349\u2013364 (2018).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"7844","key":"34373_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41586-021-03214-x","volume":"590","author":"F Kraus","year":"2021","unstructured":"Kraus, F., Roy, K., Pucadyil, T. J. & Ryan, M. T. Function and regulation of the divisome for mitochondrial fission. Nature 590(7844), 57\u201366 (2021).","journal-title":"Nature"},{"issue":"23","key":"34373_CR35","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1056\/NEJMra1215233","volume":"369","author":"SL Archer","year":"2013","unstructured":"Archer, S. L. Mitochondrial dynamics\u2013mitochondrial fission and fusion in human diseases. N. Engl. J. Med. 369(23), 2236\u20132251 (2013).","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"34373_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrneph.2018.9","volume":"14","author":"JM Forbes","year":"2018","unstructured":"Forbes, J. M. & Thorburn, D. R. Mitochondrial dysfunction in diabetic kidney disease. Nat. Rev. Nephrol. 14(5), 291\u2013312 (2018).","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"34373_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.chembiol.2017.12.001","volume":"25","author":"L Miret-Casals","year":"2018","unstructured":"Miret-Casals, L. et al. Identification of new activators of mitochondrial fusion reveals a link between mitochondrial morphology and pyrimidine metabolism. Cell Chem. Biol. 25(3), 268\u2013278 (2018).","journal-title":"Cell Chem. Biol."},{"issue":"12","key":"34373_CR38","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1096\/fj.201600410RR","volume":"30","author":"M Buler","year":"2016","unstructured":"Buler, M., Andersson, U. & Hakkola, J. Who watches the watchmen? Regulation of the expression and activity of sirtuins. FASEB J. 30(12), 3942\u20133960 (2016).","journal-title":"FASEB J."},{"issue":"4","key":"34373_CR39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/ki.2015.157","volume":"88","author":"S Wakino","year":"2015","unstructured":"Wakino, S., Hasegawa, K. & Itoh, H. Sirtuin and metabolic kidney disease. Kidney Int. 88(4), 691\u2013698 (2015).","journal-title":"Kidney Int."},{"issue":"1","key":"34373_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/cac2.12247","volume":"42","author":"D Wu","year":"2022","unstructured":"Wu, D. et al. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1. Cancer Commun. (Lond) 42(1), 37\u201355 (2022).","journal-title":"Cancer Commun. (Lond)"},{"issue":"3","key":"34373_CR41","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2018.01.011","volume":"27","author":"K Schmitt","year":"2018","unstructured":"Schmitt, K. et al. Circadian control of DRP1 activity regulates mitochondrial dynamics and bioenergetics. Cell Metab. 27(3), 657\u2013666 (2018).","journal-title":"Cell Metab."},{"key":"34373_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biochi.2019.12.001","volume":"70","author":"D Liang","year":"2020","unstructured":"Liang, D. et al. SIRT1\/PGC-1 pathway activation triggers autophagy\/mitophagy and attenuates oxidative damage in intestinal epithelial cells. Biochimie 70, 10\u201320 (2020).","journal-title":"Biochimie"},{"issue":"5","key":"34373_CR43","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.kint.2017.05.034","volume":"92","author":"L Daniel","year":"2017","unstructured":"Daniel, L. et al. The hallmarks of mitochondrial dysfunction in chronic kidney disease. Kidney Int. 92(5), 1051\u20131057 (2017).","journal-title":"Kidney Int."},{"key":"34373_CR44","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1152\/ajprenal.00263.2017","volume":"314","author":"MR Lynch","year":"2018","unstructured":"Lynch, M. R., Tran, M. T. & Parikh, S. M. PGC1\u03b1 in the kidney. Am. J. Physiol. Renal Physiol. 314, F1\u2013F8 (2018).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"34373_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.871357","volume":"10","author":"L Chen","year":"2022","unstructured":"Chen, L. et al. PGC-1\u03b1-mediated mitochondrial quality control: molecular mechanisms and implications for heart failure. Front. Cell Dev. Biol. 10, 871357 (2022).","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"34373_CR46","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/biom10020347","volume":"10","author":"M Fontecha-Barriuso","year":"2020","unstructured":"Fontecha-Barriuso, M. et al. The role of PGC-1\u03b1 and mitochondrial biogenesis in kidney diseases. Biomolecules 10(2), 347 (2020).","journal-title":"Biomolecules"},{"issue":"4","key":"34373_CR47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ymgme.2021.10.003","volume":"134","author":"M Gonzalez Melo","year":"2021","unstructured":"Gonzalez Melo, M. et al. A knock-in rat model unravels acute and chronic renal toxicity in glutaric aciduria type I. Mol. Genet. Metab. 134(4), 287\u2013300 (2021).","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"34373_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210617","volume":"14","author":"MM Ivanova","year":"2019","unstructured":"Ivanova, M. M., Changsila, E., Iaonou, C. & Goker-Alpan, O. Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseases. PLoS ONE 14(1), e0210617 (2019).","journal-title":"PLoS ONE"},{"issue":"4","key":"34373_CR49","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1002\/jimd.12373","volume":"44","author":"A Schumann","year":"2021","unstructured":"Schumann, A. et al. Defective lysosomal storage in Fabry disease modifies mitochondrial structure, metabolism and turnover in renal epithelial cells. J. Inherit. Metab. Dis. 44(4), 1039\u20131050 (2021).","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"34373_CR50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/jimd.12451","volume":"45","author":"T Mathis","year":"2022","unstructured":"Mathis, T. et al. Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I. J. Inherit. Metab. Dis. 45(2), 235\u2013247 (2022).","journal-title":"J. Inherit. Metab. Dis."},{"key":"34373_CR51","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"34373_CR52","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/metabo9100235","volume":"9","author":"S Behringer","year":"2019","unstructured":"Behringer, S. et al. Targeted metabolic pro-filing of methionine cycle metabolites and redox thiol pools inmammalian plasma, cells and urine. Metabolites 9, 235 (2019).","journal-title":"Metabolites"},{"key":"34373_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.579981","volume":"11","author":"L Hannibal","year":"2020","unstructured":"Hannibal, L. et al. Metabolic profiling inhuman fibroblasts enables subtype clustering in glycogen storage disease. Front. Endocrinol. (Lausanne) 11, 579981 (2020).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"34373_CR54","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/metabo12050373","volume":"12","author":"AC Bravo","year":"2022","unstructured":"Bravo, A. C. et al. Analysis of S-adenosylmethionine and S-adenosylhomocysteine: Method optimisation and profiling in healthy adults upon short-term dietary intervention. Metabolites 12, 373 (2022).","journal-title":"Metabolites"},{"key":"34373_CR55","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41419-021-03937-9","volume":"12","author":"JP Maier","year":"2021","unstructured":"Maier, J. P. et al. Inhibition of metabotropic glutamate receptor III facilitates sensitization to alkylating chemotherapeutics in glioblastoma. Cell Death Dis. 12, 723 (2021).","journal-title":"Cell Death Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34373-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34373-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34373-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T06:40:00Z","timestamp":1729406400000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-34373-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,11]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["34373"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-34373-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,11]]},"assertion":[{"value":"18 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7677"}}